Catyalyst Pharmaceutical Partners (CPRX) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.49 --0%
Financial Fact:
Loss per share - basic and diluted: -0.05
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Loss per share - basic and diluted: -0.05
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Catyalyst Pharmaceutical Partners (NASDAQ: CPRX) reported Q2 EPS of ($0.05), $0.02 better than the analyst estimate of ($0.07).
For earnings history and earnings-related data on Catyalyst Pharmaceutical Partners (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- Pavion Expands Midwest Presence Through Acquisition of Communication Company
- Metavesco's Epic Labor Reports $382,730 in August 2026 Revenue, Up Approximately 129% Year-Over-Year
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
